no image available Dickens & Co. "Beating the Odds: Sorafenib's Unexpected Boost in Metastatic Renal Cell Cancer" "Sequential Treatment Breakthrough Offers New Hope for Patients with Advanced Kidney Cancer" Price: 33.00€